ENTRY       D02340                      Drug
NAME        Loxapine (USAN/INN);
            Adasuve (TN)
PRODUCT     ADASUVE (Alexza Pharmaceuticals)
FORMULA     C18H18ClN3O
EXACT_MASS  327.1138
MOL_WEIGHT  327.808
CLASS       Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07104
            ATC code: N05AH01
            Chemical structure group: DG00897
            Product (DG00897): D02340<US> D00794<US>
EFFICACY    Minor tranquilizer, Dopamine D2 receptor antagonist, Serotonin receptor antagonist
  DISEASE   Schizophrenia [DS:H01649]
            Bipolar I disorder [DS:H01653]
TARGET      DRD2 [HSA:1813] [KO:K04145]
            HTR2A [HSA:3356] [KO:K04157]
  PATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction
            hsa04726(3356)  Serotonergic synapse
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AH Diazepines, oxazepines, thiazepines and oxepines
                 N05AH01 Loxapine
                  D02340  Loxapine (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              1st Generation/Typical
               Loxapine
                D02340  Loxapine (USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00897  Loxapine
                 D02340  Loxapine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00897  Loxapine
                D02340  Loxapine
              DG01644  CYP2D6 substrate
               DG00897  Loxapine
                D02340  Loxapine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00897  Loxapine
                 D02340  Loxapine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D02340  Loxapine (USAN/INN) &lt;US&gt;
               Serotonin
                HTR2A
                 D02340  Loxapine (USAN/INN) &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02340
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02340
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00897  Loxapine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00897  Loxapine
              DG01644  CYP2D6 substrate
               DG00897  Loxapine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00897  Loxapine
DBLINKS     CAS: 1977-10-2
            PubChem: 7849399
            ChEBI: 50841
            LigandBox: D02340
            NIKKAJI: J22.645I
ATOM        23
            1   C2y C    14.6234  -16.0394
            2   C8y C    13.7813  -14.9298
            3   C8y C    14.1165  -13.5730
            4   O2x O    15.3775  -12.9949
            5   N2x N    16.0292  -16.0646
            6   C8y C    16.6311  -13.6172
            7   C8y C    16.9176  -14.9859
            8   C8x C    13.1094  -12.6046
            9   C8x C    11.7674  -12.9927
            10  C8y C    11.4322  -14.3495
            11  C8x C    12.4393  -15.3176
            12  C8x C    18.2488  -15.4230
            13  C8x C    19.2930  -14.4886
            14  C8x C    19.0066  -13.1199
            15  C8x C    17.6752  -12.6828
            16  X   Cl   10.0674  -14.7439
            17  N1y N    13.9889  -17.2891
            18  C1x C    12.5873  -17.2891
            19  C1x C    11.8865  -18.5029
            20  N1y N    12.5873  -19.7169
            21  C1x C    13.9889  -19.7169
            22  C1x C    14.6897  -18.5029
            23  C1a C    11.8803  -20.9409
BOND        26
            1     3   4 1
            2     1   5 2
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    6  15 2
            18   10  16 1
            19    1  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 1
            25   17  22 1
            26   20  23 1
///
